Previous File
Biosimilars: A Tipping Point
Biosimilars: A Tipping Point

With biosimilars, the U.S. healthcare industry has a remarkable opportunity to make lifesaving and disease-...

Next File
Economic Outlook: Fall 2016 C-Suite Survey
Economic Outlook: Fall 2016 C-Suite Survey

The fall 2016 Economic Outlook survey polled 52 health system C-suite executives from across the U.S. on so...